Skip to search formSkip to main contentSkip to account menu

DR-3355

Known as: DR 3355, DR3355 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

LevofloxacinOfloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Excretion of Levofloxacin into Bile and Gallbladder Tissue
We evaluated the biliary excretion and penetration of levofloxacin and its optical isomer, DR3354, into gallbladder tissue. The… 
2005
2005
Important role of oxygen metabolites in quinolone antibacterial agent-induced cutaneous phototoxicity in mice
We investigated whether or not the generation of reactive oxygens and toxic photoproducts participated in the cutaneous… 
1992
1992
感染性腸炎に対するLevofloxacin (DR-3355) の臨床的研究および感染性腸炎患者における糞便中薬剤濃度と腸内菌叢の検討
1992
1992
ニューキノロン系抗菌剤levofloxacin (DR-3355) のin vitro, in vivo抗菌作用
1992
1992
Ｆｌｕｏｒｏｑｕｉｎｏｌｏｎｅ薬のヒト髄液中移行の検討 第３報 Ｌｅｖｏｆｌｏｘａｃｉｎ（ＤＲ‐３３５５）について:第3報Levonoxacin (DR-3355) について
  • 好忠 大井俊弘 後藤和也 川原元司 川原尚志 川畠一浩 永山
  • 1992
  • Corpus ID: 82999233
1992
1992
ニューキノロン系抗菌剤levofloxacin (DR-3355) のin vitro, in vivo抗菌作用
1992
1992
Levofloxacin (DR 3355), a new quniolone antibacterial agent.
1992
1992
新規キノロン系抗菌剤levofloxacin (DR-3355) に関する細菌学的評価
1992
1992
Levofloxacin (DR-3355) の嫌気性菌に対する抗菌活性
1992
1992
Levofloxacin (DR-3355) の前立腺組織内への移行